BOCA RATON, Fla.-- (BUSINESS WIRE)--March 19, 2026-- ...

Several well-established pharmaceutical companies have been selling the formulation under their own branded labels which are prominently stocked on major online pharmacy platforms ...

Key Takeaways. LGM Pharma’s Texas expansion targets commercial suppository manufacturing and broader semi-solid/liquid ...

The Central Drugs Standard Control Organisation (CDSCO) has directed all State and Union Territory Drugs Controllers to take immediate action against the manufacturing and marketing ...

CDSCO asks SLAs to cancel product permission to sodium hyaluronate eye drops 0.3% w/v: Gireesh Babu, New Delhi Friday, March 20, 2026, 08:00 Hrs [IST] The Central Drugs Standard C ...

Pharmaceutical major Dr. Reddy''s Laboratories Ltd on Saturday announced the launch of its injectable semaglutide under the brand name Obeda, a type 1 diabetes drug in India.

Generic drugmakers in India launch affordable Semaglutide versions, targeting a $1 billion diabetes and weight loss market.

Dr Reddy's Laboratories has announced the launch of its injectable semaglutide under the brand name Obeda, marking an important step in expanding access to GLP-1 receptor agonist-based therapy for the ...

Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, on Saturday announced the launch of its injectable semaglutide under the brand name Obeda®, marking an important step in expanding ...

DTAB asks govt to amend Rules to introduce separate form for bulk drug license for wholesale: Gireesh Babu, New Delhi Thursday, March 19, 2026, 08:00 Hrs [IST] The Drugs Technical ...